ACO Name and Location

Orange Accountable Care Organization of South Florida LLC
Previous Names: N/A
14750 NW 77th Court
Suite 308
Miami Lakes, FL 33016

 

ACO Primary Contact

Primary Contact Name	Lissette Exposito RN, BSN, MHSA, Founder, President and CEO
Primary Contact Phone Number	(786) 363–8500
Primary Contact Email Address	Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture
ADVANCED MEDICAL CARE ASSOCIATES PA	N
Ageless Medicine Associates Inc.	N
ANA ELOSEGUI	N
BERNARD WEINBACH MD PA	N
BROWARD MEDICAL ASSOCIATES OF SOUTH FLORIDA	N
CARDIOLOGY CONSULTANTS OF WEST BROWARD,PA	N
CHANDRAKANT SHAH MD PA	N
Charles Yanes, M.D., P.A.	N
COOPER FAMILY MEDICAL PLLC	N
EAST FLORIDA PREMIUM MEDICAL CARE LLC	N
ELIAS A M FEANNY MD PA	N
FARID MARQUEZ MD PA	N
FRANCISCO ADELQUIS CRUZ MDPA	N
GABRIEL M DESCHAMPS MD PA	N
GERARDO QUINONEZ, M.D., P.A.	N
GUS ARMENAKIS MD PA	N
HECTOR M DELGADO D O P A	N
IVAN ESPAILLAT MD PA	N
JEFFREY GREIFF	N
JEFFREY L PRESSER MD PA	N
JOSE GONZALEZ	N
LAWRENCE A BERGER MD PA	N
LAZARO VIGOA MD PA	N
LEVINSON AND CARDENAS, PA	N
LILI ESTRIN MD, PA	N
LUIS E DE ARMAS MD CORP	N
MARTIN DAYTON DO PA	N
MIAMI CENTER FOR ADVANCED CARDIOLOGY LLC	N
MICHAEL D FELDMAN DO PA	N
MICHAEL J BRAUN MD LLC	N
Milton A. Jimenez MD PA	N
MIREL SANCHEZ, M.D., P.A.	N
MY PERSONAL MD, LLC	N
OSCAR MENDEZ MD PA	N
OTTO L SECADA MD PA	N
PATRICIA BRAVO MD PA	N
PAZ ALVAREZ LLC	N
PEDRO G. ALVAREZ, D.O., P.A.	N
PEDRO ORLANDO DIAZ MD PA	N
QUALCARE MEDICAL GROUP INC	N
ROBERTO URQUIZA M D P A	N
ROMEO E ROJAS MD PA	N
SOFFER HEART INSTITUTE PA	N
SOHAIL DELFANI MD P.A.	N
SOUTH FLORIDA INTERNISTS GROUP PA	N
SUSSMAN & STALLER MD PA	N
VINCENT C CHIN M.D., P.A.	N

 

ACO governing body:

 

Member Last Name	Member First Name	Member Title/Position	Member’s Voting Power: expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if applicable
Exposito	Lissette	President, CEO & Board Chair	24%	Board Chair and Voting Member
Quintela, MD	Pablo	CMIO & Board Member	0%	Board Advisor
Weinbach, MD	Bernard	Medical Director & Board Member	18.75%	ACO Participant & Voting Member	BERNARD WEINBACH MD PA
Sanchez, MD	Mirel	Board Member	18.75%	ACO Participant & Voting Member	MIREL SANCHEZ, M.D., P.A.
Presser, MD	Jeffrey	Board Member	18.75%	ACO Participant & Voting Member	JEFFREY L PRESSER MD PA
Cooper, MD	Catherine	Board Member	18.75%	ACO Participant & Voting Member	COOPER FAMILY MEDICAL PLLC
Oliver	Mara	Board Member	1%	ACO Patient and Medicare Beneficiary Representative

 

Key ACO clinical and administrative leadership:

• ACO Executive: Lissette Exposito
• Medical Director: Mirel Sanchez, MD
• Compliance Officer: Marc Troisi
• Quality Assurance/Improvement Officer: Pablo Quintela, MD

 

Associated committees and committee leadership:

 

Committee Name	Committee Leader Name and Position
Quality and Informatics	Pablo Quintela, MD, Chair
Patient Experience	Raphael Ruiz, Chair
Finance and Contracting	Frank Exposito, Co-Chair Pablo Quintela, MD, Co-Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangement
• Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses:

• First Agreement Period
  • Performance Year 2020, $16,161,631
  • Performance Year 2019, $6,692,187
  • Performance Year 2018, $3,172,313
  • Performance Year 2017, $2,643,135

Shared Savings Distribution:

• First Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2019
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2018
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2017
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%

 

Quality Performance Results

2020 Quality Performance Results:

 

ACO #	Measure Name	Rate	ACO Mean
ACO-8 [1]	Risk Standardized, All Condition Readmission	15.94	15.38
ACO-38 [1,2]	Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions	42.91	51.34
ACO-43 [3]	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.76	1.69
ACO-13	Falls: Screening for Future Fall Risk	90.38	90.73
ACO-14	Preventive Care and Screening: Influenza Immunization	91.40	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	96.67	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plan	82.82	71.46
ACO-19	Colorectal Cancer Screening	85.20	72.59
ACO-20	Breast Cancer Screening	84.38	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	86.67	83.37
ACO-40	Depression Remission at Twelve Months	9.38	13.99
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	11.67	14.70
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	80.80	72.87

 

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

 

Payment Rule Waivers

• Skilled Nursing Facility (SNF) 3-day Rule Waiver:
  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.